Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials

Journal of Human Hypertension volume 25, pages 425–436 (2011)Cite this article

Subjects

Abstract

The oral assumption of lactotripeptides Valine–Proline–Proline (VPP) and Isoleucine–Proline–Proline (IPP) as nutraceuticals or functional foods is supposed to improve blood pressure (BP) control by angiotensin-converting enzyme-inhibition. However, data derived from clinical trials have reached conflicting conclusions. To perform a meta-analysis of placebo-controlled clinical trials evaluating the anti-hypertensive effect of lactotripeptides assumed as nutraceuticals or functional foods. Trials identified using a defined search strategy in PubMed were included in the meta-analysis, and their pooled effect was estimated with a random effects model, weighting for the inverse of the variance. Heterogeneity, publication bias, subgroup and meta-regression analyses were performed. A total of 18 trials have been identified, the clinical data of which have been clearly reported. Pooled effect of peptides was a reduction of −3.73 mm Hg (95% CI: −6.70, −1.76) for systolic blood pressure (SBP) and 1.97 mm Hg (95% CI: −3.85, −0.64) for diastolic blood pressure (DBP). The effect was more evident in Asian patients (SBP=−6.93 mm Hg (95% CI: −10.95, −2.94); DBP=−3.98 mm Hg(95% CI: −5.38, −2.44)) than in Caucasian ones (SBP=−1.17 mm Hg (95% CI: −2.82, 0.72); DBP=−0.52 mm Hg (95% CI: −1.39, 0.13)), and apparently not related to age, baseline BP values, dose of lactotripeptides assumed or length of the treatment. VPP and IPP lactotripeptides assumed as functional foods may significantly reduce SBP particularly in Asian subjects. The relevance of this findings in other ethnicities or associated with different dietary pattern should to be further investigated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Gaziano TA . Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005; 112: 3547–3553.

    Article  Google Scholar 

  2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.

    Article  Google Scholar 

  3. Lawes CM, Vanders HS, Rodgers A . Global burden of blood-pressure related disease, 2001. Lancet 2008; 371: 1513–1518.

    Article  Google Scholar 

  4. McInnes GT . Lowering blood pressure for cardiovascular risk reduction. J Hypertens Suppl 2005; 23: S3–S8.

    Article  CAS  Google Scholar 

  5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25 (6): 1105–1187.

    Article  CAS  Google Scholar 

  6. Appel LJ, Giles TD, Black HR, Izzo Jr JL, Materson BJ, Oparil S, et al., American Society of Hypertension Writing Group. ASH position paper: dietary approaches to lower blood pressure. J Clin Hypertens 2009; 11 (7): 358–368.

    Article  CAS  Google Scholar 

  7. Miller III ER, Erlinger TP, Appel LJ . The effects of macronutrients on blood pressure and lipids: an overview of the DASH and OmniHeart trials. Curr Atheroscler Rep 2006; 8 (6): 460–465.

    Article  CAS  Google Scholar 

  8. Pérez-López FR, Chedraui P, Haya J, Cuadros JL . Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 2009; 64 (2): 67–79.

    Article  Google Scholar 

  9. Pripp AH . Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr Res 2008; 52: 1–9.

    Google Scholar 

  10. Murray BA, FitzGerald RJ . Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 2007; 13: 773–791.

    Article  CAS  Google Scholar 

  11. FitzGerald RJ, Meisel H . Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 2000; 84 (Suppl. 1): S33–S37.

    CAS  PubMed  Google Scholar 

  12. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T . A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767–771.

    Article  CAS  Google Scholar 

  13. Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H, Takahashi T . Hypotensive effect of sour milk in subjects with mold or moderate hypertension. J Jpn Soc Nutr Food Sci 2001; 54: 347–354.

    Article  CAS  Google Scholar 

  14. Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y . Hypotensive effects of the tablets containing ‘Lactotripeptides (VPP, IPP)’. J Nutr Food 2001; 4 (3): 51–61.

    Google Scholar 

  15. Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T . Clinical effect of new sour milk drink on mild or moderate hypertensive subjects. J New Rem Clin 2002; 51 (1): 61–69.

    Google Scholar 

  16. Seppo L, Kerojoki O, Suomalainen T, Korpela R . The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension: a pilot study on humans. Milchwissenschaft 2002; 57: 124–127.

    CAS  Google Scholar 

  17. Seppo L, Jauhiainen T, Poussa T, Korpela R . A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 2003; 77: 326–330.

    Article  CAS  Google Scholar 

  18. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 2004; 17: 701–706.

    Article  Google Scholar 

  19. Tuomilehto J, Lindstrom J, Hyyrynen J, Korpela R, Karhunen M-L, Mikkola L et al. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with milk hypertension. J Hum Hypertens 2004; 18: 795–802.

    Article  CAS  Google Scholar 

  20. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y . Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005; 24: 257–265.

    Article  Google Scholar 

  21. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M, Korpela R . Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 2005; 18: 1600–1605.

    Article  Google Scholar 

  22. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 2005; 94: 84–91.

    Article  CAS  Google Scholar 

  23. Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food 2005; 8: 423–430.

    Article  CAS  Google Scholar 

  24. Engberink MF, Schouten EG, Kok FJ, van Mierlo LAJ, Brouwer IA, Geleijnse JM . Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension 2008; 51 (2): 399–405.

    Article  CAS  Google Scholar 

  25. van der Zander K, Bots ML, Bak AAA, Koning MMG, de Leeuw PW . Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am J Clin Nutr 2008; 88: 1697–1702.

    Article  CAS  Google Scholar 

  26. van Mierlo LAJ, Koning MMG, van der Zander K, Draijer R . Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. Am J Clin Nutr 2009; 89: 617–623.

    Article  CAS  Google Scholar 

  27. de Leeuw PW, van der Zander K, Kroon AA, Rennenberg RM, Koning MM . Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Press 2009; 18 (1–2): 44–50.

    Article  CAS  Google Scholar 

  28. Yoshizawa M, Maeda S, Miyaki A, Misono M, Choi Y, Shimojo N et al. Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women. Am J Physiol Heart Circ Physiol 2009; 297 (5): H1899–H1903.

    Article  CAS  Google Scholar 

  29. Cicero AFG, Rosticci M, Veronesi M, Bacchelli S, Strocchi E, Melegari C et al. Haemodynamic effects of lactotripeptides from fermentation by lactobacillus helveticus in normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, cross-over clinical trial. J Med Food 2010 (in press).

  30. DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.

    Article  CAS  Google Scholar 

  31. Higgins JP, Thompson SG, Deeks JJ, Altman DG . Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560.

    Article  Google Scholar 

  32. Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.

    Article  CAS  Google Scholar 

  33. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F . Methods for Meta-Analysis in Medical Research. John Wiley & Sons: Chichester, UK, 2000.

    Google Scholar 

  34. Bax L, Yu LM, Ikeda N, Tsuruta N, Moons KGM . MIX: comprehensive free software for meta-analysis of causal research data. Version 1.54; 2006 (www.mix-for-meta-analysis.info).

  35. Xu JY, Qin LQ, Wang PY, Li W, Chang C . Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008; 24 (10): 933–940.

    Article  CAS  Google Scholar 

  36. Verdecchia P, Angeli F, Mazzotta G, Ambrosio G, Reboldi G . Angiotensin receptor blockers in hypertension. New insights from Japan. Hypertens Res 2010; 33 (5): 394–397.

    Article  CAS  Google Scholar 

  37. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al., Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369 (9567): 1090–1098.

    Article  CAS  Google Scholar 

  38. Law MR, Morris JK, Wald NJ . Use of Blood Pressure Lowering Drugs in the Prevention of Cardiovascular Disease: Meta-analysis of 147 Randomised Trials in the Context of Expectations from Prospective Epidemiological Studies. BMJ 2009; 338: b1665.

    Article  CAS  Google Scholar 

  39. Nakamura T, Mizutani J, Sasaki K, Yamamoto N, Takazawa K . Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study. J Med Food 2009; 12 (6): 1–6.

    Article  Google Scholar 

  40. Geleijnse JM, Engberink MF . Lactopeptides and human blood pressure. Curr Opin Lipidol 2010; 21 (1): 58–63.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aging and Kidney diseases Department, Internal Medicine, Sant'Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy,

    A F G Cicero, B Gerocarni, L Laghi & C Borghi

Authors
  1. A F G Cicero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Gerocarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Laghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Borghi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A F G Cicero.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cicero, A., Gerocarni, B., Laghi, L. et al. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. J Hum Hypertens 25, 425–436 (2011). https://doi.org/10.1038/jhh.2010.85

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2010.85

Keywords

This article is cited by

Search

Advanced search

Quick links